GBp 18.25
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 5.88 Million | 3.79 Million | 1.2 Million | 139.22 Thousand | 305.49 Thousand | 122.55 Thousand |
Selling, General and Administrative Expenses | 4.64 Million | 3.79 Million | 1.2 Million | 139.22 Thousand | 223.7 Thousand | 405.75 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.23 Million | - | - | - | - | - |
Cost and Expenses | 5.88 Million | 3.79 Million | 1.2 Million | 139.22 Thousand | 305.49 Thousand | 122.55 Thousand |
Operating Income | -5.88 Million | -3.79 Million | -1.2 Million | -139.22 Thousand | -223.7 Thousand | -405.75 Thousand |
Interest Expense | - | 6751.00 | 3579.00 | 5112.00 | - | - |
Income Tax Expense | - | - | 3580.00 | 5111.00 | - | - |
Earnings before Tax | -5.88 Million | -3.8 Million | -1.2 Million | -144.33 Thousand | -309.6 Thousand | -125.43 Thousand |
Net Income | -5.88 Million | -3.8 Million | -1.2 Million | -149.44 Thousand | -309.6 Thousand | -125.43 Thousand |
Earnings Per Share Basic | -0.05 | -0.04 | -0.02 | -0.00 | - | - |
Earnings Per Share Diluted | -0.05 | -0.04 | -0.02 | -0.00 | - | - |
Weighted Average Shares Outstanding | 109.74 Million | 105.33 Million | 79.03 Million | 79.03 Million | - | - |
Weighted Average Shares Outstanding (Diluted) | 109.74 Million | 105.33 Million | 79.03 Million | 79.03 Million | - | - |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -5.88 Million | -3.79 Million | - | - | -86.9 Thousand | -268.95 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 1430.60 | 1430.60 | 1311.20 | 5.88 Million | 1.31 Million | 3.26 Million |
Selling, General and Administrative Expenses | 1130.60 | 1130.60 | 1009.35 | - | 1 Million | 2.62 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 300.00 | 300.00 | -603.7 Thousand | -1.23 Million | - | -635.1 Thousand |
Cost and Expenses | 1430.60 | 1430.60 | 1311.20 | 5.88 Million | 1.31 Million | 3.26 Million |
Operating Income | -1430.60 | -1430.60 | -1311.20 | -5.88 Million | -1.31 Million | -3.26 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -2.86 Million | - | -1311.20 | - | 4904.00 | -1631.60 |
Earnings before Tax | -1430.60 | -1430.60 | -1306.30 | -5.88 Million | -1.3 Million | -3.27 Million |
Net Income | -1430.60 | -1430.60 | -1306.30 | -5.88 Million | -1.3 Million | -3.27 Million |
Earnings Per Share Basic | - | -0.01 | -0.01 | - | -0.01 | -0.03 |
Earnings Per Share Diluted | - | -0.01 | -0.01 | - | -0.01 | -0.03 |
Weighted Average Shares Outstanding | 145.16 Million | 145.16 Million | 113.82 Million | 109.74 Million | 112.33 Million | 105.66 Million |
Weighted Average Shares Outstanding (Diluted) | 145.16 Million | 145.16 Million | 113.82 Million | 109.74 Million | 112.32 Million | 105.66 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -2.86 Million | - | 4.90 | - | 4904.00 | -3.26 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
ACROW
688070
BIOFILCHEM
ASSA
BFS-PE
SACH